Clinical Trials Directory

Trials / Unknown

UnknownNCT04681014

CTEPH in Patients With Prior Pulmonary Embolism and Risk Score Validation

Evidence-based Detection of CTEPH in Patients With Prior Pulmonary Embolism: Risk Score Evaluation and Validation.

Status
Unknown
Phase
Study type
Observational
Enrollment
1,218 (actual)
Sponsor
iPHNET (italian Pulmonary Hypertension NETwork) · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

CTEPH-SOLUTION aims to create a risk score for the early detection of Chronic Thrombo-Embolic Pulmonary Hypertension (CTEPH) among patients with previous pulmonary embolism. The risk score, created on retrospective data, will be validated on newly diagnosed pulmonary embolism patients.

Detailed description

CTEPH-SOLUTION is a multicenter observational cross-sectional and prospective study in patients with a prior and new diagnosis of pulmonary embolism. Patients with prior pulmonary embolism will be screened at baseline with doppler echocardiography: an estimated sPAP ≥ 40 mmHg will be the indication for pulmonary hypertension detection. After 24 months from baseline, patients will be followed-up for CTEPH detection. CTEPH diagnosis will be carried out according to the current ESC/ERS guidelines. Incident (pulmonary embolism episode at least three months before the baseline) and prevalent (pulmonary embolism episode) patients will be enrolled.

Conditions

Timeline

Start date
2016-01-21
Primary completion
2020-07-31
Completion
2022-07-31
First posted
2020-12-23
Last updated
2020-12-23

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04681014. Inclusion in this directory is not an endorsement.